Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Idraparinux

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Idraparinux?

Idraparinux is an investigational drug.

There have been 5 clinical trials for Idraparinux. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2003.

The most common disease conditions in clinical trials are Venous Thrombosis, Thrombosis, and Pulmonary Embolism. The leading clinical trial sponsors are Sanofi and [disabled in preview].

Recent Clinical Trials for Idraparinux
Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial FibrillationSanofiPhase 3
Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic ApproachSanofiPhase 3
Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower LimbsSanofiPhase 3

See all Idraparinux clinical trials

Clinical Trial Summary for Idraparinux

Top disease conditions for Idraparinux
Top clinical trial sponsors for Idraparinux

See all Idraparinux clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.